Scottish Enterprise right this moment, 18 August 2022, revealed that 2021/22 continued to be a document yr for its early-stage funding actions.
The enterprise company, which has been investing in early-stage companies since 2003, alongside native, nationwide, and worldwide personal sector buyers, recorded funding of £50.71 million into 102 early-stage excessive development funding alternatives – which in flip helped leverage an extra £257 million from personal sector buyers leading to over £307 million of development finance for revolutionary, bold early-stage Scottish companies final yr.
2021/22 proved to be the strongest on document for attracting worldwide co-investment with greater than half of the finance leveraged coming from international Enterprise Capital companies and company buyers. This was on account of ongoing work to construct investor networks internationally, complementing the work of the Scotland’s International Funding Plan, and underlines the vibrancy of Scotland’s funding market and the worldwide enchantment of Scottish corporations.
2021/22 additionally noticed an growing variety of companies persevering with their development journey underneath new possession having efficiently reached the stage the place exit alternatives can be found for early buyers, permitting Scottish Enterprise to generate £106 million of revenue.
Adrian Gillespie, Chief Govt at Scottish Enterprise, mentioned: “Final yr was an distinctive yr for our early-stage funding actions. Not solely did we see a wholesome variety of offers, however our maturing portfolio of investee corporations noticed robust exit alternatives permitting us to generate vital revenue to re-invest within the financial system.”
A key precedence for Scottish Enterprise is making certain that early-stage entrepreneurial corporations with excessive development potential can entry the finance they should begin up and develop. Alongside co-investment, Scottish Enterprise additionally offers specialist, tailor-made recommendation and funding assist to determine buyers and to lift finance via its Monetary Readiness Service. 269 corporations had been supported by this service final yr to efficiently elevate exterior finance.
Adrian continued, “It’s massively gratifying to see the companies we work with go from energy to energy, attracting additional funding, and growing revolutionary merchandise, providers, and enterprise fashions, offering excessive worth employment alternatives proper throughout Scotland.”
“Our assist for quick rising, revolutionary corporations is especially necessary at a time when there are appreciable challenges going through many companies. We very a lot recognise the significance of attracting new funding to the long run prosperity of Scotland.”
Notable investments throughout the yr included:
Verlume, an funding into Aberdeen-based subsea know-how firm alongside Edinburgh-based enterprise capital agency Par Fairness and included current backers, Orchard Enterprise Capital raised £2.5 million in an extra funding spherical. The funding, alongside a current rebrand, will permit the corporate to capitalise on the rising alternatives inside the vitality transition and develop the enterprise at tempo.
Speaking Medicines, an funding alongside new worldwide investor Thairm Bio and current buyers Tern and SIS ventures in a £1.5m funding spherical to assist its ambitions for growth into the US. Scottish Enterprise offered wrap round recommendation and grant funding via its SMART: SCOTLAND programme. The Glasgow-based affected person intelligence firm has developed an information platform – PatientMetRx – which makes use of machine studying and pure language processing to offer science-based insights.
In4Derm, is a spin out from the world main College of Dundee’s Faculty of Life Sciences and a improbable instance of an revolutionary Scottish early-stage enterprise with international development ambitions. An funding through our Scottish Enterprise Fund alongside o2h Ventures in a £1.6m pre-Collection A funding spherical to assist the continued growth and growth of its pipeline of first-in-class anti-inflammatory and orphan indications therapeutics. The medicine developed by In4Derm will assist sufferers internationally and create jobs in Scotland whereas contributing to the continued development of its vibrant life sciences sector.
Boundary, an funding alongside associate Fairness Hole and Skyscanner co-founder Gareth Williams and Co-founders Robin Knox & Paul Walton and chairman, Richard Lewis into this Scottish residence safety start-up. £3.7m was raised to scale up the Edinburgh-based firm which launched its first product in March 2021. The funds raised might be used to develop the enterprise over 18 months because it seems to a extra bold funding spherical sooner or later.
Kynos Therapeutics, a spin out of the College of Edinburgh, raised £9m to progress growth of therapies on the interface of irritation, immunity and metabolism. The preliminary financing spherical was led by Epidarex and joined by IP Group and Scottish Enterprise.
Notable exits realised throughout the yr included:
Present Well being, a co-investment alongside Par Fairness, was acquired by US based mostly Greatest Purchase for $400m which considerably enhances the corporate’s potential to develop at scale via entry to first-class provide and logistic networks while rising their Scottish and US based mostly staff.
Smarter Grid Options, a spin out of Strathclyde College, was acquired by Mitsubishi Electrical Company and has launched into the subsequent stage in its international development journey while sustaining and rising their Scottish presence – a co-investment with Scottish Fairness Companions.
Spoonfed, an funding alongside Fairness Hole, was acquired by 365, permitting the enterprise to proceed to comprehend its full potential, notably within the US and European markets from its base in Glasgow using the worldwide community, and assist 365 can present.